Relationship between cerebrospinal fluid/serum albumin quotient and phenotype in amyotrophic lateral sclerosis: a retrospective study on 328 patients

Federico Verde,Ivan Ferrari,Alessio Maranzano,Emilio Ciusani,Silvia Torre,Ilaria Milone,Eleonora Colombo,Alberto Doretti,Silvia Peverelli,Antonia Ratti,Luca Maderna,Barbara Poletti,Stefano Messina,Claudia Morelli,Vincenzo Silani,Nicola Ticozzi
DOI: https://doi.org/10.1007/s10072-023-06604-3
2023-01-17
Neurological Sciences
Abstract:BackgroundWe analysed the relationship between cerebrospinal fluid (CSF)/serum albumin quotient (Q-Alb) and phenotype in a large cohort of patients with amyotrophic lateral sclerosis (ALS).MethodsThree hundred twenty-eight single-centre consecutive patients with ALS were evaluated for Q-Alb, basic epidemiological and clinical data, motor phenotype, cognitive/behavioural impairment, clinical staging, clinical and neurophysiological indexes of upper (UMN) and lower motor neuron (LMN) dysfunction, and presence of ALS gene mutations.ResultsQ-Alb did not correlate with age but was independently associated with sex, with male patients having higher levels than female ones; the site of onset was not independently associated with Q-Alb. Q-Alb was not associated with motor phenotype, cognitive/behavioural impairment, disease stage, progression rate, survival, or genetic mutations. Among measures of UMN and LMN dysfunction, Q-Alb only had a weak positive correlation with an electromyography-based index of active limb denervation.ConclusionPrevious work has documented increased Q-Alb in ALS compared to unaffected individuals. This, together with the absence of associations with nearly all ALS phenotypic features in our cohort, suggests dysfunction of the blood-CSF barrier as a shared, phenotype-independent element in ALS pathophysiology. However, correlation with the active denervation index could point to barrier dysfunction as a local driver of LMN degeneration.
neurosciences,clinical neurology
What problem does this paper attempt to address?